Penumbra Gross Profit 2014-2024 | PEN

Penumbra annual/quarterly gross profit history and growth rate from 2014 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Penumbra gross profit for the quarter ending September 30, 2024 was $0.200B, a 12.71% increase year-over-year.
  • Penumbra gross profit for the twelve months ending September 30, 2024 was $0.731B, a 15.33% increase year-over-year.
  • Penumbra annual gross profit for 2023 was $0.683B, a 27.55% increase from 2022.
  • Penumbra annual gross profit for 2022 was $0.535B, a 12.58% increase from 2021.
  • Penumbra annual gross profit for 2021 was $0.475B, a 40.57% increase from 2020.
Penumbra Annual Gross Profit
(Millions of US $)
2023 $683
2022 $535
2021 $475
2020 $338
2019 $372
2018 $293
2017 $217
2016 $171
2015 $124
2014 $83
2013 $58
Penumbra Quarterly Gross Profit
(Millions of US $)
2024-09-30 $200
2024-06-30 $163
2024-03-31 $181
2023-12-31 $187
2023-09-30 $178
2023-06-30 $167
2023-03-31 $151
2022-12-31 $138
2022-09-30 $135
2022-06-30 $134
2022-03-31 $127
2021-12-31 $125
2021-09-30 $120
2021-06-30 $119
2021-03-31 $111
2020-12-31 $94
2020-09-30 $91
2020-06-30 $65
2020-03-31 $88
2019-12-31 $98
2019-09-30 $96
2019-06-30 $94
2019-03-31 $84
2018-12-31 $79
2018-09-30 $75
2018-06-30 $72
2018-03-31 $67
2017-12-31 $64
2017-09-30 $55
2017-06-30 $51
2017-03-31 $48
2016-12-31 $47
2016-09-30 $43
2016-06-30 $41
2016-03-31 $40
2015-12-31 $36
2015-09-30 $33
2015-06-30 $27
2015-03-31 $27
2014-12-31
2014-09-30 $21
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.945B $1.059B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.628B 25.94
Intuitive Surgical (ISRG) United States $186.738B 97.63
Alcon (ALC) Switzerland $45.674B 32.15
IQVIA Holdings (IQV) United States $39.509B 21.77
Edwards Lifesciences (EW) United States $38.832B 24.66
IDEXX Laboratories (IDXX) United States $35.456B 41.76
DexCom (DXCM) United States $26.916B 40.53
Waters (WAT) United States $22.926B 33.90
SONOVA HOLDING (SONVY) Switzerland $21.977B 0.00
STERIS (STE) Ireland $21.252B 24.49
Hologic (HOLX) United States $18.417B 19.43
Fresenius Medical Care AG KGaA (FMS) Germany $12.517B 12.85
Sysmex ADR (SSMXY) Japan $12.405B 38.90
Globus Medical (GMED) United States $11.099B 28.27
Teleflex (TFX) United States $9.197B 14.67
Masimo (MASI) United States $8.639B 41.80
Glaukos (GKOS) United States $7.682B 0.00
PROCEPT BioRobotics (PRCT) United States $5.022B 0.00
Integer Holdings (ITGR) United States $4.514B 25.59
Inari Medical (NARI) United States $3.035B 0.00
TransMedics (TMDX) United States $2.870B 90.96
Veracyte (VCYT) United States $2.868B 86.84
LivaNova (LIVN) United Kingdom $2.823B 16.30
Nihon Kohden (NHNKY) Japan $2.488B 18.90
Elekta AB (EKTAY) Sweden $2.336B 19.03
Tandem Diabetes Care (TNDM) United States $2.188B 0.00
Integra LifeSciences Holdings (IART) United States $1.968B 10.29
RxSight (RXST) United States $1.881B 0.00
Alphatec Holdings (ATEC) United States $1.334B 0.00
Artivion (AORT) United States $1.214B 80.50
Pulse Biosciences (PLSE) United States $1.106B 0.00
OPKO Health (OPK) United States $1.011B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.939B 15.96
IRadimed (IRMD) United States $0.707B 38.23
ORTHOFIX MEDICAL INC (OFIX) United States $0.696B 0.00
Pacific Biosciences Of California (PACB) United States $0.668B 0.00
OrthoPediatrics (KIDS) United States $0.666B 0.00
SiBone (SIBN) United States $0.649B 0.00
Mesa Laboratories (MLAB) United States $0.638B 15.10
Paragon 28 (FNA) United States $0.591B 0.00
AxoGen (AXGN) United States $0.582B 0.00
Treace Medical Concepts (TMCI) United States $0.492B 0.00
CVRx (CVRX) United States $0.377B 0.00
ClearPoint Neuro (CLPT) United States $0.370B 0.00
Tactile Systems Technology (TCMD) United States $0.366B 19.81
Delcath Systems (DCTH) United States $0.304B 0.00
AngioDynamics (ANGO) United States $0.291B 0.00
Semler Scientific (SMLR) United States $0.276B 18.50
Sight Sciences (SGHT) United States $0.235B 0.00
Inogen (INGN) United States $0.224B 0.00
NeuroPace (NPCE) United States $0.221B 0.00
Accuray (ARAY) United States $0.210B 0.00
Nevro (NVRO) United States $0.199B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
908 Devices (MASS) United States $0.126B 0.00
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
Sensus Healthcare (SRTS) United States $0.107B 15.95
EDAP TMS S.A (EDAP) France $0.101B 0.00
WORK Medical Technology Group (WOK) China $0.090B 0.00
LENSAR (LNSR) United States $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.079B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Lucid Diagnostics (LUCD) United States $0.054B 0.00
Rapid Micro Biosystems (RPID) United States $0.053B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.029B 0.00
Precision Optics (POCI) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.010B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00